Submit manuscript...
Journal of
eISSN: 2373-4396

Cardiology & Current Research

Commentary Volume 15 Issue 2

Mechanical ventilation in CoVID-19 patients: A point of view

Vinko Tomicic1,2

1Intensive Care Unit, Regional Clinical Hospital of Antofagasta, Chile
2Professor of Surgery, University of Antofagasta, Chile

Correspondence: Vinko Tomicic, Unidad de Cuidados Intensivos 2° piso Hospital Clínico Regional de Antofagasta, Azapa 5935, Antofagasta, Chile, Tel +56227583969

Received: January 07, 2022 | Published: March 4, 2022

Citation: Tomicic V. Mechanical ventilation in CoVID-19 patients: A point of view. J Cardiol Curr Res. 2022;15(2):25-26. DOI: 10.15406/jccr.2022.15.00546

Download PDF

Keywords

CoVID-19, SDRA, Mechanical Ventilation

Abbreviations

MV, mechanical ventilation; ICU, intensive care unit; VILI, ventilator induced lung injury; ARDS, acute respiratory distress síndrome; SILI, self-inflicted lung injury; TC, computed tomography; LRM, lung recruitment maneuvers; VT, tidal volumen

Commentary

Coronavirus infection can lead to severe acute respiratory failure, whose hospital mortality can reach 40% in patients requiring mechanical ventilation (MV).1 As it is an emerging pathology, we have just learned that it is a steroid-modulable disease, which has a high thrombotic potential, a high prevalence of delirium and infectious complications, that determine a long stay in the intensive care unit (ICU). A long weaning process forces us to use tracheostomy.2

There are few data regarding ventilatory management, however, volume control and pressure control ventilation are the most common ventilatory modes used, similar to classic acute respiratory distress syndrome (ARDS). But independent of the ventilatory modes, plateau pressure, driving pressure and PEEP are the cornerstone target to adjust MV for avoids ventilator induced lung injury (VILI). Avoiding the indiscriminate use of C-NAF and awake prone position we could also limit self-inflicted lung injury (SILI).3,4

Ongoing studies indicate that the pathophysiological mechanisms of oxygenation disorders in patients with CoVID-19 are related to the redistribution of blood flow, which may differ from other forms of ARDS.5 For the same reason, the magnitude of the compromise in the computed tomography (TC) is not faithfully related to the oxygenation compromise. This characteristic could favor the response of these patients to prone position (PP). In classic ARDS, PP has shown good results and in COVID-19 has also been used with good response.6–8

The different pulmonary phenotypes (H and L) make difficult adjust mechanical ventilation because these patients show different potencial of recruitment and forces us to adjust the ventilation individually.9 In fact, lung recruitment maneuvers (LRM) have been widely incorporated into the therapeutic armamentarium in ICU, however, the concept that these maneuvers and decremental PEEP titration in patients with classic ARDS who need vasopressor drugs, were associated with higher mortality has recently emerged.10

The L phenotype (Low elastance/high compliance) does not benefit from LRM and high levels of PEEP, because the potential of recruitment is low, therefore these patients should be ventilated with moderate levels of PEEP (around 10 cmH2O) and a tidal volumen (VT) around 6 to 8ml/kg PBW, always trying to maintain a driving pressure less than 15cmH2O. To the other hand, H phenotipe (High elastance/low compliance) early in the evolution could respond to LRM, however, at a late stage of evolution (greater than 7days) these maneuvers could be deleterious.9 It should be noted that these patients are especially susceptible to developing pneumomediastinum and pneumothorax.11

At the second week, on the CT appear peribronchovascular and subpleural condensation, named “crazy pavement pattern” and traction bronchiectasis, determining a organizing pneumonia.12 A CT in this period it is essential to determine the degree of organization and consequently decide additional use of steroids as metilprednisolone.13,14

Conclusion

A significant percentage of patients (50-70%) require early PP to overcome hypoxemia and although most respond, it does not ensure a good hospital outcome, late prone position has uncertain results. If the prone position fails, the use of extracorporeal oxygenation support should be considered.15

Acknowledgment

None.

Conflicts of interest

Author declares there are no conflicts of interest

Funding

There was no funding for this report.

References

  1. King CS, Sahjwani D, Brown AW, et al. Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure. Plos One. 2020;15(11): e0242651.
  2. Ulloa R, Born P, Kattan E, et al. Soporte ventilatorio en pacientes críticos con Covid -19: a 18 meses de la pandemia en Chile. Chilean Journal of Anesthesia. 2021;50(6):815-824.
  3. Laffey JG, Bellani G, Pham T, et al. Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study. Intensive Care Med. 2016;42(12):1865–1876.
  4. Weaver L, Das A, Safaran S, et al. High risk of patient self-inflicted lung injury in COVID-19 with frequently encountered spontaneous breathing patterns: a computational modelling study. Ann Intensive Care. 2021;11:109.
  5. Zarantonello F, Andreatta G, Sella N, et al. Prone position and lung ventilation and perfusion matching in acute respiratory failure due to COVID-19. Am J Respir Crit Care Med. 2020;202:278–279.
  6. Ferrando C, Suarez-Sipmann F, Mellado-Artigas R, et al. Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS. Intensive Care Med. 2020;46(12):2200-2211.
  7. Mora-Arteaga JA, Bernal-Ramírez OJ, Rodríguez SJ. Effect of mechanical ventilation in the prone position in patients with acute respiratory distress syndrome. Una revisión sistemática y metanálisis Med Intensiva. 2015;39(6):352-365.
  8. Shelhamer MC, Wesson PD, Solari IL, et al. Prone Positioning in Moderate to Severe Acute Respiratory Distress Syndrome Due to COVID-19: A Cohort Study and Analysis of Physiology. J Intensive Care Med. 2021;36(2):241–252.
  9. Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46:1099–1102.
  10. Zampieri FG, Costa EL, Iwashyna ThJ, et al. Heterogeneous effects of alveolar recruitment in acute respiratory distress syndrome: a machine learning reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial. British Journal of Anaesthesia. 2019;123(1):88-95.
  11. Mohan V, Tauseen RA. Spontaneous pneumomediastinum in COVID-19. BMJ Case Rep. 2020;13:e236519.
  12. Rasuli B. Crazy paving pattern in COVID-19 pneumonia: Case study. Radiopaedia.
  13. Pan F, Ye T, Sun P, et al. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020:295(3):715–721.
  14. Edalatifard M, Akhtari M, Salehi M, et al. Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J. 2020;56.
  15. Diaz RA, Graf J, Zambrano JM, et al. ECMO for COVID-19-Associated Severe ARDS in Chile: A Nationwide Incidence and Cohort Study. Am J Respir Crit Care Med. 2021;204(1):34–43.
Creative Commons Attribution License

©2022 Tomicic. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.